Market Research Logo

Idera Pharmaceuticals Inc - Financial and Strategic SWOT Analysis Review

Idera Pharmaceuticals Inc - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Idera Pharmaceuticals Inc (Idera) is a clinical stage biotechnology company which focuses on the discovery, development and commercialization of drug candidates for the treatment of life threatening diseases. It develops DNA and RNA based drug candidates that are targeted against toll-like receptors (TLR) for the treatment of infectious diseases and which can be used as vaccine adjuvants. The company initiated a research program employing its gene silencing technologies to inhibit the production of disease-associated proteins by targeting RNA. The company designs and formulates proprietary TLR agonists and antagonists to modulate immune responses. The lead product in the pipeline is IMO-2125, IMO-8400, IMO-9200, and antagonist of TLRs 7, 8, and 9 for the treatment of lupus. Idera is headquartered in Massachusetts, the US.

Idera Pharmaceuticals Inc Key Recent Developments


May 04,2017: Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 18,2017: Idera Pharmaceuticals Announces Organizational Update
Mar 15,2017: Idera Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update
Oct 28,2016: Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results
Aug 24,2016: Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Idera Pharmaceuticals Inc - Key Facts 5
Idera Pharmaceuticals Inc - Key Employees 6
Idera Pharmaceuticals Inc - Key Employee Biographies 7
Idera Pharmaceuticals Inc - Major Products and Services 8
Idera Pharmaceuticals Inc - History 9
Idera Pharmaceuticals Inc - Company Statement 11
Idera Pharmaceuticals Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Company Overview 16
Idera Pharmaceuticals Inc - Strengths 17
Idera Pharmaceuticals Inc - Weaknesses 18
Idera Pharmaceuticals Inc - Opportunities 19
Idera Pharmaceuticals Inc - Threats 20
Idera Pharmaceuticals Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Idera Pharmaceuticals Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
May 04, 2017: Idera Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 30
Apr 18, 2017: Idera Pharmaceuticals Announces Organizational Update 33
Mar 15, 2017: Idera Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update 34
Oct 28, 2016: Idera Pharmaceuticals Reports Third Quarter 2016 Financial Results 37
Aug 24, 2016: Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology 40
Aug 02, 2016: Idera Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update 41
May 09, 2016: Idera Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update 43
Mar 12, 2016: Idera Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Provides Corporate Update 45
Mar 10, 2016: Idera Pharmaceuticals Reports Fourth Quarter And Year End 2015 Financial Results And Provides Corporate Update 47
Jan 06, 2016: Idera Pharmaceuticals Announces Appointment of Dr. Maxine Gowen to Its Board of Directors 49
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54
List of Tables
Idera Pharmaceuticals Inc, Key Facts 5
Idera Pharmaceuticals Inc, Key Employees 6
Idera Pharmaceuticals Inc, Key Employee Biographies 7
Idera Pharmaceuticals Inc, Major Products and Services 8
Idera Pharmaceuticals Inc, History 9
Idera Pharmaceuticals Inc, Other Locations 15
Idera Pharmaceuticals Inc, Key Competitors 20
Idera Pharmaceuticals Inc, Ratios based on current share price 21
Idera Pharmaceuticals Inc, Annual Ratios 22
Idera Pharmaceuticals Inc, Annual Ratios (Cont...1) 23
Idera Pharmaceuticals Inc, Interim Ratios 25
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Idera Pharmaceuticals Inc, Recent Deals Summary 29
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53
List of Figuress
Idera Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Idera Pharmaceuticals Inc, Ratio Charts
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Idera Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report